Diabetes Care Devices - Singapore

In Singapore, revenue in the Diabetes Care Devices market market is projected to reach US$56.35m in 2024.
The revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 14.45%, leading to a market volume of US$110.70m by 2029.
When compared globally, the highest revenue will be generated the United States, where it is expected to reach US$11.71bn in 2024.
Singapore's Diabetes Care Devices market is witnessing a surge in innovation, driven by increasing awareness and government initiatives promoting better diabetes management solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Singapore is witnessing substantial growth, fueled by factors such as the increasing prevalence of diabetes, advancements in technology, and heightened awareness of diabetes management among healthcare professionals and patients alike.

Customer preferences: In Singapore, consumers are increasingly prioritizing personalized diabetes management solutions that integrate seamlessly into their daily lives. This shift reflects a growing preference for smart diabetes care devices, such as continuous glucose monitors and insulin delivery systems, that offer real-time data and insights. Additionally, the rise of telehealth services is enabling patients to receive tailored consultations and support remotely, aligning with the fast-paced lifestyle of urban dwellers. Cultural emphasis on health and wellness is further driving demand for innovative products that empower individuals to take control of their diabetes care.

Trends in the market: In Singapore, the Diabetes Care Devices Market is experiencing a significant shift towards smart technology integration, with an increasing adoption of continuous glucose monitors and automated insulin delivery systems that provide real-time data insights. This trend is being fueled by a rising demand for personalized solutions that fit into the fast-paced urban lifestyle. Furthermore, the expansion of telehealth services is enhancing patient access to specialized consultations and ongoing support. As health and wellness become cultural priorities, industry stakeholders must innovate to meet the expectations of empowered consumers seeking effective diabetes management solutions.

Local special circumstances: In Singapore, the Diabetes Care Devices Market is shaped by the nation’s robust healthcare infrastructure and high technology adoption rate. The government’s commitment to health promotion through initiatives like the Healthier SG program encourages early intervention in chronic diseases, including diabetes. Additionally, Singapore's multicultural society influences a demand for tailored diabetes solutions that respect diverse dietary practices. The regulatory environment is also proactive, facilitating swift approval processes for innovative medical devices, thereby accelerating market growth and enhancing patient access to cutting-edge diabetes management technologies.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Singapore is significantly influenced by macroeconomic factors such as national economic stability, healthcare spending, and demographic trends. A strong economy allows for increased public and private investment in healthcare technology, fostering innovation and enhancing the availability of advanced diabetes management devices. Fiscal policies aimed at subsidizing healthcare costs and promoting preventive care further bolster market growth. Additionally, the rising prevalence of diabetes, driven by lifestyle changes and an aging population, underscores the urgent need for effective diabetes care solutions, propelling demand for cutting-edge medical devices.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.